September 14, 2010 -- Yunnan Walvax Biotechnology, a company that specializes in human vaccines, will IPO on the Shenzhen ChiNext Exchange. Although most financial details were not released, the company did say it would issue 25 million new shares, bringing its share count up to 100 million. More details....
